New Oral Anticoagulants versus Warfarin for Cerebral Venous Thrombosis: A Multi-Center, Observational Study
Mohammad Wasay, Maria Khan, Haris Majid Rajput, Salman Farooq, Mohammed Ibrahim Memon, Suhail Abdulla AlRukn, Abdul Malik, Foad Abd-Allah, Raja Farhat Shoaib, Rizwana Shahid, Sadia Nishat, Safia Awan
J Stroke. 2019;21(2):220-223.   Published online 2019 May 31     DOI: https://doi.org/10.5853/jos.2019.00150
Citations to this article as recorded by Crossref logo
Choice and Timing of Antithrombotic after Ischemic Stroke, Intracerebral Hemorrhage or Cerebral Venous Thrombosis
Dylan Ryan, Tarun Girotra, Wuwei Feng
CNS & Neurological Disorders - Drug Targets.2024; 23(2): 135.     CrossRef
Use of MLC901 in cerebral venous sinus thrombosis: Three case reports
Anita Ante Arsovska, Narayanaswamy Venketasubramanian
World Journal of Clinical Cases.2024; 12(2): 346.     CrossRef
Direct oral anticoagulants compared to warfarin in long‐term management of cerebral venous thrombosis: A comprehensive meta‐analysis
Redoy Ranjan, Gie Ken‐Dror, Pankaj Sharma
Health Science Reports.2024;[Epub]     CrossRef
Dabigatran etexilate versus warfarin in cerebral venous thrombosis in Chinese patients (CHOICE-CVT): An open-label, randomized controlled trial
Hongrui Ma, Yaqin Gu, Tingting Bian, Haiqing Song, Zhi Liu, Xunming Ji, Jiangang Duan
International Journal of Stroke.2024;[Epub]     CrossRef
COVID and Vaccine-related Cerebral Venous Thrombosis
Shafaq Saleem, Sajid Hameed, Mohammad Wasay
Journal of Stroke Medicine.2024; 7(1): 7.     CrossRef
Drying up the drip- A case report
Poornima Nair, Sivakumar K
IP Indian Journal of Neurosciences.2024; 10(1): 43.     CrossRef
Efficacy and Safety of Direct Oral Anticoagulants in Cerebral Venous Thrombosis: Meta-Analysis of Randomized Clinical Trials
Xi Chen, Linjuan Guo, Meiming Lin
Clinical and Applied Thrombosis/Hemostasis.2024;[Epub]     CrossRef
Cerebral vein thrombosis: from risk factors to recanalization and clinical outcomes. A review
Tatiana Yu. Batenkova
Consilium Medicum.2024; 26(2): 117.     CrossRef
Efficacy and safety of rivaroxaban versus warfarin in the management of unusual site deep vein thrombosis: a retrospective cohort study
Linlin Fu, Wenting Cai, Hanyang Li, Dan Han, Li Li, Baoyan Wang
Frontiers in Pharmacology.2024;[Epub]     CrossRef
Cerebral Venous Thrombosis: Medical Management vs. Endovascular Therapy
Sabrina L. Begley, Timothy G. White, Jeffrey M. Katz
Current Treatment Options in Neurology.2023; 25(6): 169.     CrossRef
Protocol of a Multicenter Cohort Observational Study of Cerebral Venous Thrombosis in China Mainland
Min Li, Xiaogang Gao, Qi Yang, Xuxiang Zhang, Jian Chen, Ran Meng, Xunming Ji
Cerebrovascular Diseases.2023; 52(2): 130.     CrossRef
Pathophysiology, diagnosis and management of cerebral venous thrombosis: A comprehensive review
Redoy Ranjan, Gie Ken-Dror, Pankaj Sharma
Medicine.2023; 102(48): e36366.     CrossRef
Safety and efficacy of Direct Oral Anticoagulants in cerebral venous thrombosis: A meta‐analysis
Gaurav Nepal, Sanjeev Kharel, Riwaj Bhagat, Yow Ka Shing, Megan Ariel Coghlan, Prasanta Poudyal, Rajeev Ojha, Gentle Sunder Shrestha
Acta Neurologica Scandinavica.2022; 145(1): 10.     CrossRef
Cavernous Sinus Thrombosis and Blindness Complicating Dental Infection
Emily Ming Choo Ng, Othmaliza Othman, Li Yen Chan, Nor Akmal Bahari
Cureus.2022;[Epub]     CrossRef
Cerebral venous thrombosis
D.R. Safina, R.G. Esin, A.A. Khakimova, L.R. Alimbekova
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova.2022; 122(3): 11.     CrossRef
Efficacy and safety of the direct oral anti‐coagulants in patients with cerebral vein thrombosis: A systematic review and meta‐analysis
Nicoletta Riva, Francesca Galea, Isaac Buhagiar, Alex Gatt, Jean Calleja‐Agius
British Journal of Haematology.2022; 198(1): 165.     CrossRef
Cerebral venous sinus thrombosis as the initial presentation of essential thrombocythemia - A case report and literature review
Qudsum Yousaf, Haseeb Amad Khan, Fateen Ata, Adeel Ahmad Khan, Nadia Karim, Zohaib Yousaf
eNeurologicalSci.2022; 27: 100398.     CrossRef
Addendum to guidelines on the investigation and management of venous thrombosis at unusual sites (Br. J. Haematol. 2012;159:28–38): Use of Direct Oral Anticoagulants
Renu Riat, Keith Gomez
British Journal of Haematology.2022; 198(1): 46.     CrossRef
Vision Preservation in COVID-Related Cerebral Sinovenous Thrombosis With Optic Nerve Sheath Fenestration
Andrew B. Johnston, Asim F. Choudhri, Violiza Inoa, Lauren C. Ditta
Journal of Neuro-Ophthalmology.2022; 42(2): e463.     CrossRef
Warfarin versus factor Xa inhibitors in the long-term treatment of cerebral venous sinus thrombosis a single-center retrospective analysis
Alexei Christodoulides, Bradley N. Bohnstedt
eNeurologicalSci.2022; 28: 100412.     CrossRef
Long-Delayed Manifestation of COVID-19 Coagulopathy Presenting with Severe Cerebral Venous Thrombosis Causes Massive Brain Hemorrhage
Mardjono Tjahjadi, Sinatrya Caropeboka, Christian Permana, Krisandi Susanto, Eka Susanto
Asian Journal of Neurosurgery.2022; 17(02): 342.     CrossRef
Direct Oral Anticoagulants Versus Vitamin K Antagonists in Cerebral Venous Thrombosis: A Systematic Review and Meta-Analysis
Shadi Yaghi, Ian J. Saldanha, Chelsea Misquith, Bashar Zaidat, Asghar Shah, Kareem Joudi, Bianca Persaud, Feras Abdul Khalek, Liqi Shu, Adam de Havenon, Eva A. Mistry, Ekaterina Bakradze, Eric D. Goldstein, John Reagan, Aikaterini Theodorou, Lina Palaiodi
Stroke.2022; 53(10): 3014.     CrossRef
Patient-guided modifications of oral anticoagulant drug intake during Ramadan fasting: a multicenter cross-sectional study
AbdulAziz Batarfi, Haitham Alenezi, Abdulrahman Alshehri, Saud Balelah, Hameedullah Kazim, Mohammed Algthami, Mariam M. Hussain, Nada Alshehri, Rahaf Alsharif, Hadeel Ashour, Mutaz Althobaiti, Shomokh Alotaibi, Helmuth Steinmetz, Christian Foerch
Journal of Thrombosis and Thrombolysis.2021; 51(2): 485.     CrossRef
Direct oral anticoagulants for unusual‐site venous thromboembolism
Nicoletta Riva, Walter Ageno
Research and Practice in Thrombosis and Haemostasis.2021; 5(2): 265.     CrossRef
Rivaroxaban for the treatment of cerebral venous thrombosis
Sara Esmaeili, Meysam Abolmaali, Sobhan Aarabi, Mohammad Reza Motamed, Samira Chaibakhsh, Mohammad Taghi Joghataei, Mohammad Mojtahed, Zahra Mirzaasgari
BMC Neurology.2021;[Epub]     CrossRef
Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review
Gauruv Bose, Justin Graveline, Vignan Yogendrakumar, Risa Shorr, Dean A Fergusson, Gregoire Le Gal, Jonathan Coutinho, Marcelo Mendonça, Miguel Viana-Baptista, Simon Nagel, Dar Dowlatshahi
BMJ Open.2021; 11(2): e040212.     CrossRef
Internal Jugular Vein Thrombosis: Etiology, Symptomatology, Diagnosis and Current Treatment
Alba Scerrati, Erica Menegatti, Matilde Zamboni, Anna Maria Malagoni, Mirko Tessari, Roberto Galeotti, Paolo Zamboni
Diagnostics.2021; 11(2): 378.     CrossRef
Ischemic Stroke in the Young
Samuel A. Berkman, Shlee S. Song
Clinical and Applied Thrombosis/Hemostasis.2021; 27: 107602962110022.     CrossRef
Cerebral venous thrombosis and its hemorrhagic complications
A. A. Kulesh
Neurology, Neuropsychiatry, Psychosomatics.2021; 13(2): 10.     CrossRef
Impact of anticoagulation status on recanalization and outcome of cerebral venous thrombosis
Ashish K. Dubey, Jayantee Kalita, Sarvesh K. Chaudhary, Usha K. Misra
Journal of Clinical Neuroscience.2021; 89: 43.     CrossRef
Neurocritical Care of the Pregnant Patient
Deepa Malaiyandi, Elysia James, Lindsay Peglar, Nurose Karim, Nicholas Henkel, Kristin Guilliams
Current Treatment Options in Neurology.2021;[Epub]     CrossRef
Cerebral Venous Thrombosis Caused by Spontaneous Intracranial Hypotension: A Case Report
Kyung-Jae Lee, Sung-Tae Kim, Won-Hee Lee, Keun Soo Lee, Sung Hwa Paeng, Se-young Pyo
Korean Journal of Neurotrauma.2021; 17(2): 174.     CrossRef
The Novel Oral Anticoagulants (NOACs) for the Treatment of Cerebral Venous Thrombosis: A Case Study of 32 Vietnamese Patients
Thang H. Nguyen, Triet M. Ngo, Bau V. Phan, Binh N. Pham, Nha T. T. Dao, An T. T. Nguyen, Trung Q. Nguyen, Hoang T. Phan
Journal of Stroke Medicine.2021; 4(2): 105.     CrossRef
Evidence-Based Minireview: Should warfarin or a direct oral anticoagulant be used in patients presenting with thrombosis in the splanchnic or cerebral veins?
Carol Mathew, Marc Zumberg
Hematology.2021; 2021(1): 100.     CrossRef
Cerebral and Splanchnic Vein Thrombosis: Advances, Challenges, and Unanswered Questions
Nicoletta Riva, Walter Ageno
Journal of Clinical Medicine.2020; 9(3): 743.     CrossRef
Comparing the efficacy and safety of direct oral anticoagulants with vitamin K antagonist in cerebral venous thrombosis
Grace K. H. Lee, Vanessa H. Chen, Choon-Han Tan, Aloysius S. T. Leow, Wan-Yee Kong, Ching-Hui Sia, Nicholas W. S. Chew, Tian-Ming Tu, Bernard P. L. Chan, Leonard L. L. Yeo, Vijay K. Sharma, Benjamin Y. Q. Tan
Journal of Thrombosis and Thrombolysis.2020; 50(3): 724.     CrossRef
Preliminary findings regarding the use of direct oral anticoagulants in cerebral venous thrombosis
Andrew Hsu, Hetal Mistry, Nupur Lala, John L. Reagan
Clinical Neurology and Neurosurgery.2020; 198: 106204.     CrossRef
Anticoagulation in splanchnic and cerebral vein thrombosis: An international vignette‐based survey
Nicoletta Riva, Marc Carrier, Alex Gatt, Walter Ageno
Research and Practice in Thrombosis and Haemostasis.2020; 4(7): 1192.     CrossRef
Comparison of Novel Oral Anticoagulants and Vitamin K Antagonists in Patients With Cerebral Venous Sinus Thrombosis on Efficacy and Safety: A Systematic Review
Hongjie Li, Meiling Yao, Songjie Liao, Jingyan Chen, Jian Yu
Frontiers in Neurology.2020;[Epub]     CrossRef
Non-Vitamin K Antagonist Oral Anticoagulants in Medical Conditions at High Risk of Thromboembolism beyond Atrial Fibrillation
Keun-Sik Hong
Journal of Stroke.2019; 21(3): 259.     CrossRef
Cortical venous thrombosis – A case series and review of recent updates
Shivangi Garg, Dinesh Chaudhari, PushpendraNath Renjen, Kamal Ahmad, Abhas Kumar, Rajendra Pradhan, Anjali Mishra
Apollo Medicine.2019; 16(4): 232.     CrossRef